China Health Technology Group Holding Company Limited (CN Health Tech) announced a leadership transition effective 25 June 2026. Chair and executive director Bi Xue has stepped down as chief executive officer to focus on other personal commitments but retains her positions as board chair and executive director.
Concurrent with Bi’s change, the board appointed Leung Ka Wai, aged 33, as both executive director and chief executive officer. Leung brings more than a decade of business-management and customer-development experience, including:
• Manager, Skydragon Logistics (May 2012 – April 2015), overseeing Hong Kong branch operations and logistics coordination. • Customer service officer, SecureCom Media (October 2015 – March 2017), responsible for expanding clientele in Hong Kong and mainland China. • Independent non-executive director, Lapco Holdings (GEM: 8472) since June 2024. • Executive director, Sterling Group Holdings (Main Board: 1825) from January 2024 to May 2025.
Leung has entered into a one-year service contract with CN Health Tech, receiving annual remuneration of HK$24,000 (approximately 0.02 million). He will hold office until the next annual general meeting and is eligible for re-election under the company’s articles of association.
The board confirmed that Leung holds no shares in CN Health Tech, has no relationships with existing directors, senior management, or substantial shareholders, and meets all disclosure requirements under the Hong Kong Listing Rules.
Following these changes, the board consists of three executive directors—Bi Xue, Leung Ka Wai, and Wong Hoi Ying—and three independent non-executive directors—Chau Wing Nam, Liu Shuhua, and Li Liangjie.
Comments